Before considering what is at present known about the relationship of autoimmunity to rheumatoid arthritis, I shall outline briefly the concept of autoimmunity itself and its possible relationships to disease. Until a few years ago the many forms of immunity which had been studied in man and animals showed one feature in commonthat they dealt with various immune responses made by the individual as a result of contacts with the outside world. Immune responses, whether involving antibodies or cellular reactions, were typically elicited in the body by contacts with micro-organisms but also with certain other foreign materials, chiefly protein but sometimes carbohydrate, which were antigenic and could stimulate the formation of antibodies. Proteins and carbohydrates are characteristic components of tissue; the response of individuals of one species to implantation or injection of the tissues of another species can be called a 'hetero-immune' response. Individuals can also respond immunologically to the tissues of another individual of the same species and well-known examples of this 'iso-immune' responsiveness occur in incompatible transfusion and in graft rejection. It has been recognized for a long time that, as well as disposing or helping to dispose of, intrusive antigenic entities, an immune response can sometimes prove harmful to the individual producing it, so that local or even general tissue damage results from the pharmacological effects or cellular events which accompany or follow the antigenantibody reaction. The possibility that tissue damage could result from an immune reaction of the body against one or more of its own componentsan autoimmune reactionwas not, until quite recently, seriously considered because 5 it was thought that such a response was totally prohibited by, as it were, natural law.
A large number of experimental and clinical observations made during the last decade or so, however, have provided overwhelming evidence to the contrary and it can be stated categorically that prohibition in the body of autoimmune responses is not total and that they do occur in a variety of different situations. The converse situationspecific unresponsiveness to a specific antigenhas been produced experimentally by a number of procedures; one of these, exposure of the individual to the antigen in question during the immunological immaturity of fletal life, is presumably an important mechanism which normally prevents autoimmunization with the body's own antigenic components.
The detailed mechanism of unresponsiveness is imperfectly understood but it is clear, from experiment and from clinical observation, that it can break down, wear off or otherwise be rendered ineffective. When such a breakdown occurs an autoimmune response becomes possible, but does not necessarily, of itself, lead to tissue damage or disease. Its consequences probably depend on many factors, including the distribution and accessibility of the self-antigen, the nature of the immune responsehumoral or cellularand perhaps also on the combining and other biological properties of the y-globulin molecules of which auto-antibodies, as well as other antibodies, are composed. To determine the relationship of autoimmunity to disease is therefore often a major problem. Sometimes, as in autoimmune hemolytic anzemia, it is not too difficult: here the patient's red cells are demonstrably sensitized with specific auto-antibody and it can be shown that the practical effect of this auto-antibody is to shorten the life span of the red cells in the circulation. In another well-known example of human autoimmunityautoimmune thyroiditisthe role of auto-antibodies in producing or prolonging the disease is not so easily defined. Patients with Hashimoto's disease pro-duce high-titre auto-antibodies reacting with thyroglobulin and with specific thyroid epithelial antigens but, although antibodies against the latter have a cytotoxic effect on thyroid cells in tissue culture, the histology of the thyroid in these conditions suggests that the thyroiditis is at least in part mediated by a cellular hypersensitivity; animal experiments confirm this. In a third category is myocardial disease, which provides instances of auto-antibodies arising as a result of tissue damage; for example, some patients with ischiemic heart disease or after mitral valvotomy develop auto-antibodies specific for heart muscle antigen but apparently without pathogenic effect. Immunological findings in rheumatoid arthritis pose some particularly puzzling questions because, although patients with this condition sometimes produce several of the different auto-antibodies found in other connective tissue disease, their most consistent serological feature is that they give positive tests for rheumatoid serum factors and at first sight it is difficult to see how these fit into the autoimmune category. Rheumatoid factors are essentially anti-y-globulin factors (Table 1) reacting with human and foreign y-globulin in an immunological manner, recognized in several different tests of which the best known are the Rose-Waaler and the latex agglutination tests. The distribution of rheumatoid factor activity in patients and in healthy subjects and the immunological properties of the various factors have been and are being exhaustively studied; much information relating to the genetics, structure and specificity of antibody protein has resulted. The current, most widely accepted view of the nature of rheumatoid factor is that it is primarily an abnormal antibodylike protein capable of reacting with the yglobulin of the individual in whom it occurs, especially if the y-globulinthe reactantis denatured or altered in molecular shape. Such denaturation can be brought about in antibody molecules by their combination with antigen, as well as by physical procedures such as heating. If this interpretation of its nature is a true one, then the problem is to determine what is the stimulus for rheumatoid factor production in rheumatoid arthritis; whether, for example, it could be antigen-antibody complexes in the tissues, per- toid synovitis is very similar to what is seen in lymph nodes which have received strong antigenic stimulation, and is readily reproduced in the joints of immune animals by intra-articular injection of antigen, as Dumonde & Glynn (1962) have shown. The follicles represent centres of immunologically competent and active cells; they are also seen in hyperplastic lymph nodes in rheumatoid arthritis cases (Fig 4) .
The question then arises: what antibodies are these germinal centres producing and in response Kaplan & Vaughan (1959) and McCormick (1963) have studied these tissues by immunofluorescent methods and Figs 5 and 6 illustrate their results which Dr W Douglas, applying these methods, has confirmed in my laboratory. Fig 5 is a germinal centre from the same rheumatoid lymph node as before. A section of tissue was cut in a cryostat and treated with a horse antiserum specific for human 19S macro-y-globulin, the serum fraction in which rheumatoid factor 61.-3 activity resides. This antiserum had previously been conjugated with fluorescein and thus, whereever it combined with 19S macroglobulin in the section, the combination was made visible on viewing the section by ultraviolet microscopy: in this and in other germinal centres it could be seen that the central cells contained 19S macroglobulin as a cytoplasmic constituent. By using fluoresceinconjugated denatured human y-globulin in a similar way rheumatoid factor itself could be located (Fig 6) , and it appeared in some, though not all of these germinal centres. Similar studies of joint tissues show that rheumatoid factor is produced not only in lymph nodes which are normal sites of antibody production but also in germinal centres and plasma cells in the affected synovial membrane itself.
If we postulate that production of rheumatoid factor is an abnormal immunological response on the part of an individual to the stimulus ofhis own antibody y-globulin altered by combination with antigen, it could be envisaged that such antigenantibody complexes might well involve autoantibodies as well as hetero-antibodies. What, then, is the evidence that rheumatoid arthritis patients produce auto-antibodies in the same way as, for example, patients with systemic lupus erythematosus? Positive LE cell teststhe hallmark of auto-antibody production in SLEare seldom found in rheumatoid arthritis patients, at least in our experience. However, the immunofluorescent test for anti-nuclear auto-antibodies, which gives nearly 100% positive results in SLE, is also positive in a proportion of cases of classical or definite rheumatoid arthritis; according to our investigation of cases at Taplow, about 20 % show this phenomenon (Fig 7) . Apart from systemic lupus, a higher incidence of positive antinuclear factor (ANF) tests has been reported only in Sjogren's syndrome, where rheumatoid factor tests are usually positive also. Some of the other auto-antibodies characteristic of SLE are less often found in rheumatoid arthritis than ANF but, nevertheless, are present significantly more often than in normal individuals.
In summary, therefore, the changes which I have described in the synovial membranes of affected joints and in the lymph nodes are essentially immunological changes and are intimately concerned with the production of rheumatoid factors. Secondly, there are reasonable grounds for thinking that rheumatoid factors are antibodies directed at altered human y-globulinthat is to say they are auto-antibodies of a rather special sort. Thirdly, we know that some rheumatoid patients produce auto-antibodies, such as antinuclear factor, of the type which are characteristic of systemic lupus erythematosus. It therefore seems to be a reasonable working hypothesis Perhaps the best way a pwdiatrician can introduce this subject to an assembly of orthopedic surgeons is to remind them that quite often the beginning of the disorder is without obvious arthritis. Recognition of the disease can be difficult when high fever, a rash, extreme malaise, a polymorphonuclearcytosis, adenopathy, a raised sedimentation rate and possibly pneumonitis and pericarditis are the main clinical features. Arthritis is not long delayed and the diagnosis becomes clearer. Of course this acute onset is not invariable
